V. McLaughlin

Risk assessment in pulmonary arterial hypertension (PAH): Insights from the GRIPHON study

H. Ghofrani, R. Benza, G. Simonneau, 2018, Pneumologie.

Delivery of intravenous treprostinil at low infusion rates using a miniaturized infusion pump in patients with pulmonary arterial hypertension

R. Barst, M. Gomberg-Maitland, V. McLaughlin, 2006, The journal of vascular access.

Seralutinib for the Treatment of Pulmonary Arterial Hypertension (PAH): Results From the Phase 2 TORREY Trial

H. Ghofrani, K. Chin, J. Vachiéry, 2023, D106. HOT OFF THE PRESSES! LATE BREAKERS IN PULMONARY VASCULAR DISEASE.